{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,13]],"date-time":"2026-11-13T09:35:47Z","timestamp":1794562547616,"version":"4.9.1"},"reference-count":19,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["international-journal-of-gynecological-cancer.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Gynecological Cancer"],"published-print":{"date-parts":[[2021,6]]},"DOI":"10.1136\/ijgc-2021-002489","type":"journal-article","created":{"date-parts":[[2021,5,6]],"date-time":"2021-05-06T23:53:50Z","timestamp":1620345230000},"page":"829-834","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":31,"title":["Role of adjuvant radiation therapy after radical hysterectomy in patients with stage IB cervical carcinoma and intermediate risk factors"],"prefix":"10.1016","volume":"31","clinical-trial-number":[{"clinical-trial-number":"nct01101451","registry":"10.18810\/clinical-trials-gov"}],"author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6260-5353","authenticated-orcid":false,"given":"Dimitrios","family":"Nasioudis","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nawar A","family":"Latif","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert L","family":"Giuntoli II","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ashley F","family":"Haggerty","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lori","family":"Cory","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah H","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark A","family":"Morgan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emily M","family":"Ko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1136\/ijgc-2021-002489_bb0010","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1089\/jwh.2011.3385","article-title":"Cervical cancer trends in the United States: a 35-year population-based analysis","volume":"21","author":"Adegoke","year":"2012","journal-title":"J Womens Health"},{"key":"10.1136\/ijgc-2021-002489_bb0015","unstructured":"Cervical Cancer Statistics, Centers for Disease Control and Prevention. Available: https:\/\/www.cdc.gov\/cancer\/cervical\/statistics\/index.htm [Accessed 10 Dec 2020]."},{"key":"10.1136\/ijgc-2021-002489_bb0020","doi-asserted-by":"crossref","first-page":"64","DOI":"10.6004\/jnccn.2019.0001","article-title":"Cervical cancer, version 3.2019, NCCN clinical practice guidelines in oncology","volume":"17","author":"Koh","year":"2019","journal-title":"J Natl Compr Canc Netw"},{"key":"10.1136\/ijgc-2021-002489_bb0025","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1097\/IGC.0000000000001216","article-title":"The European Society of Gynaecological Oncology\/European Society for Radiotherapy and Oncology\/European Society of Pathology guidelines for the management of patients with cervical cancer","volume":"28","author":"Cibula","year":"2018","journal-title":"Int J Gynecol Cancer"},{"key":"10.1136\/ijgc-2021-002489_bb0030","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1006\/gyno.1999.5387","article-title":"A randomized trial of pelvic radiation therapy versus no further therapy in selected patients with stage IB carcinoma of the cervix after radical hysterectomy and pelvic lymphadenectomy: a gynecologic Oncology Group study","volume":"73","author":"Sedlis","year":"1999","journal-title":"Gynecol Oncol"},{"key":"10.1136\/ijgc-2021-002489_bb0035","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/0090-8258(90)90139-C","article-title":"Morbidity and survival patterns in patients after radical hysterectomy and postoperative adjuvant pelvic radiotherapy","volume":"36","author":"Fiorica","year":"1990","journal-title":"Gynecol Oncol"},{"key":"10.1136\/ijgc-2021-002489_bb0040","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1016\/j.ygyno.2018.10.018","article-title":"Surgical treatment of \"intermediate risk\" lymph node negative cervical cancer patients without adjuvant radiotherapy \u2013 a retrospective cohort study and review of the literature","volume":"151","author":"Cibula","year":"2018","journal-title":"Gynecol Oncol"},{"key":"10.1136\/ijgc-2021-002489_bb0045","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1136\/ijgc-2019-000445","article-title":"Analysis of isolated loco-regional recurrence rate in intermediate risk early cervical cancer after a type C2 radical hysterectomy without adjuvant radiotherapy","volume":"29","author":"van der Velden","year":"2019","journal-title":"Int J Gynecol Cancer"},{"key":"10.1136\/ijgc-2021-002489_bb0050","unstructured":"Cervical cancer: adjuvant therapy and surgery (CERVANTES), Gynecologic Cancer Intergroup. Available: https:\/\/gcigtrials.org\/system\/files\/IR%20CC%20GCIG%202019-V5%20%20-%20%20Read-Only.pdf [Accessed 10 Dec 2020]."},{"key":"10.1136\/ijgc-2021-002489_bb0055","doi-asserted-by":"crossref","DOI":"10.3390\/jcm9113545","article-title":"Impact of adjuvant radiotherapy on survival outcomes in intermediate-risk, early-stage cervical cancer: analyses regarding surgical approach of radical hysterectomy","volume":"9","author":"Kim","year":"2020","journal-title":"J Clin Med"},{"key":"10.1136\/ijgc-2021-002489_bb0060","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.ijrobp.2005.10.019","article-title":"A phase III randomized trial of postoperative pelvic irradiation in stage IB cervical carcinoma with poor prognostic features: follow-up of a Gynecologic Oncology Group study","volume":"65","author":"Rotman","year":"2006","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1136\/ijgc-2021-002489_bb0065","doi-asserted-by":"crossref","DOI":"10.3802\/jgo.2020.31.e54","article-title":"Management of patients with intermediate-risk early stage cervical cancer","volume":"31","author":"Cibula","year":"2020","journal-title":"J Gynecol Oncol"},{"key":"10.1136\/ijgc-2021-002489_bb0070","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1136\/ijgc-00009577-200403000-00015","article-title":"Prognostic factors in FIGO stage IB cervical cancer without lymph node metastasis and the role of adjuvant radiotherapy after radical hysterectomy","volume":"14","author":"Ayhan","year":"2004","journal-title":"Int J Gynecol Cancer"},{"key":"10.1136\/ijgc-2021-002489_bb0075","doi-asserted-by":"crossref","first-page":"S170","DOI":"10.1016\/j.ygyno.2007.07.026","article-title":"Early stage cervical cancer: adjuvant treatment in negative lymph node cases","volume":"107","author":"Sartori","year":"2007","journal-title":"Gynecol Oncol"},{"key":"10.1136\/ijgc-2021-002489_bb0080","doi-asserted-by":"crossref","DOI":"10.1186\/s12957-016-0931-4","article-title":"Analysis of the effect of adjuvant radiotherapy on outcomes and complications after radical hysterectomy in FIGO stage IB1 cervical cancer patients with intermediate risk factors (GOTIC study)","volume":"14","author":"Nakamura","year":"2016","journal-title":"World J Surg Oncol"},{"key":"10.1136\/ijgc-2021-002489_bb0085","doi-asserted-by":"crossref","DOI":"10.3802\/jgo.2020.31.e35","article-title":"Chemoradiotherapy is not superior to radiotherapy alone after radical surgery for cervical cancer patients with intermediate-risk factor","volume":"31","author":"Kim","year":"2020","journal-title":"J Gynecol Oncol"},{"key":"10.1136\/ijgc-2021-002489_bb0090","doi-asserted-by":"crossref","first-page":"106866","DOI":"10.18632\/oncotarget.22437","article-title":"Effectiveness of adjuvant systemic chemotherapy for intermediate-risk stage IB cervical cancer","volume":"8","author":"Matsuo","year":"2017","journal-title":"Oncotarget"},{"key":"10.1136\/ijgc-2021-002489_bb0095","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1016\/j.ygyno.2016.10.022","article-title":"Can chemotherapy boost the survival benefit of adjuvant radiotherapy in early stage cervical cancer with intermediate risk factors? a population based study","volume":"143","author":"Mahmoud","year":"2016","journal-title":"Gynecol Oncol"},{"key":"10.1136\/ijgc-2021-002489_bb0100","doi-asserted-by":"crossref","first-page":"3406","DOI":"10.1245\/s10434-017-6031-z","article-title":"2017 update on the Querleu\u2013Morrow classification of radical hysterectomy","volume":"24","author":"Querleu","year":"2017","journal-title":"Ann Surg Oncol"}],"container-title":["International Journal of Gynecological Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1048891X24004092?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1048891X24004092?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/ijgc-2021-002489","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,22]],"date-time":"2025-07-22T22:39:08Z","timestamp":1753223948000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1048891X24004092"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,6]]},"references-count":19,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2021,6]]}},"alternative-id":["S1048891X24004092"],"URL":"https:\/\/doi.org\/10.1136\/ijgc-2021-002489","relation":{},"ISSN":["1048-891X"],"issn-type":[{"value":"1048-891X","type":"print"}],"subject":[],"published":{"date-parts":[[2021,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Role of adjuvant radiation therapy after radical hysterectomy in patients with stage IB cervical carcinoma and intermediate risk factors","name":"articletitle","label":"Article Title"},{"value":"International Journal of Gynecological Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1136\/ijgc-2021-002489","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2021 IGCS and ESGO 2021. No commercial re-use. See rights and permissions. Published by BMJ.","name":"copyright","label":"Copyright"}]}}